Multi-factorial role of GnRH-I and GnRH-II in the human ovary

被引:77
作者
Leung, PCK [1 ]
Cheng, CK
Zhu, XM
机构
[1] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V6H 3V5, Canada
[2] Affiliated Hosp Nantong Med Coll, Dept Obstet & Gynecol, Jiangsu, Peoples R China
关键词
ovarian functions; gonadotropin-releasing hormone; signal transduction mechanism;
D O I
10.1016/S0303-7207(03)00076-5
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Normal ovarian functions are regulated by a wide variety of endocrine hormones, local paracrine and autocrine factors, which functionally interact with each other in a highly coordinated fashion. Recent findings have demonstrated that both forms of gonadotropin-releasing hormone (GnRH-I and GnRH-II) are expressed in various compartments of the human ovary including the granulosa-luteal cells, ovarian surface epithelial cells and ovarian tumors, and their expressions have been shown to be tightly regulated by gonadal steroids and gonadotropins. Functionally, these neuropeptides exert diverse biological effects in the ovary via binding to their cognate receptors, supporting the notion that these peptides act as paracrine and autocrine factors in modulating local ovarian functions. In this review, we will summarize recent literatures regarding the regulation of GnRH-I and GnRH-II gene expressions in the human ovary, and discuss the possible signal transduction mechanisms by which these hormones exert their actions in the gonad. Recent cloning of the second form of the GnRH receptor (GnRH-II receptor) in primates and other vertebrates demonstrated that it was structurally, and thus, functionally distinct from the GnRH-I receptor. Cell proliferation studies showed that GnRH-II inhibited the growth of human ovarian cancer cells that express GnRH-II but not GnRH-I receptor, indicating that the GnRH-II binding sites are functional in these cells. However, it remains unknown if GnRH-II receptor is expressed as a full-length, properly processed and functional gene transcript in humans, and its potential physiological roles such as differential regulation of gonadotropin secretion, neuroendocrine modulation and female sexual behavior await further investigation. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:145 / 153
页数:9
相关论文
共 78 条
[11]   Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappa B control [J].
Chu, ZL ;
McKinsey, TA ;
Liu, L ;
Gentry, JJ ;
Malim, MH ;
Ballard, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) :10057-10062
[12]   Cloning and gene expression of a novel human ribonucleoprotein [J].
Conklin, DC ;
Rixon, MW ;
Kuestner, RE ;
Maurer, MF ;
Whitmore, TE ;
Millar, RP .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2000, 1492 (2-3) :465-469
[13]   GONADOTROPIN-RELEASING-HORMONE AND ITS ANALOGS [J].
CONN, PM ;
CROWLEY, WF .
ANNUAL REVIEW OF MEDICINE, 1994, 45 :391-405
[14]   HIGH-AFFINITY BINDING AND DIRECT ANTIPROLIFERATIVE EFFECTS OF LUTEINIZING-HORMONE-RELEASING HORMONE ANALOGS IN HUMAN ENDOMETRIAL CANCER CELL-LINES [J].
EMONS, G ;
SCHRODER, B ;
ORTMANN, O ;
WESTPHALEN, S ;
SCHULZ, KD ;
SCHALLY, AV .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06) :1458-1464
[15]  
EMONS G, 1993, CANCER RES, V53, P5439
[16]   LHRH might act as a negative autocrine regulator of proliferation of human ovarian cancer [J].
Emons, G ;
Weiss, S ;
Ortmann, O ;
Gründker, C ;
Schulz, KD .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 142 (06) :665-670
[17]  
Emons G, 1996, INT J ONCOL, V9, P1129
[18]   Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks [J].
Fauser, BCJM ;
Devroey, P ;
Yen, SSC ;
Gosden, R ;
Crowley, WF ;
Baird, DT ;
Bouchard, P .
HUMAN REPRODUCTION, 1999, 14 (11) :2681-2686
[19]  
Fink G., 1988, P1349
[20]   ESTRADIOL STIMULATES CELL-GROWTH AND SECRETION OF PROCATHEPSIN-D AND A 120-KILODALTON PROTEIN IN THE HUMAN OVARIAN-CANCER CELL-LINE BG-1 [J].
GALTIERDEREURE, F ;
CAPONY, F ;
MAUDELONDE, T ;
ROCHEFORT, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (06) :1497-1502